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The G-protein coupled parathyroid hormone 2 receptor (PTH2R) is concentrated in
endocrine and limbic regions in the forebrain. Its endogenous ligand, tuberoinfundibular
peptide of 39 residues (TIP39), is synthesized in only two brain regions, within the poste-
rior thalamus and the lateral pons.TIP39-expressing neurons have a widespread projection
pattern, which matches the PTH2R distribution in the brain. Neuroendocrine centers includ-
ing the preoptic area, the periventricular, paraventricular, and arcuate nuclei contain the
highest density of PTH2R-positive networks. The administration of TIP39 and an antag-
onist of the PTH2R as well as the investigation of mice that lack functional TIP39 and
PTH2R revealed the involvement of the PTH2R in a variety of neural and neuroendocrine
functions. TIP39 acting via the PTH2R modulates several aspects of the stress response.
It evokes corticosterone release by activating corticotropin-releasing hormone-containing
neurons in the hypothalamic paraventricular nucleus. Block ofTIP39 signaling elevates the
anxiety state of animals and their fear response, and increases stress-induced analge-
sia. TIP39 has also been suggested to affect the release of additional pituitary hormones
including arginine-vasopressin and growth hormone. A role of the TIP39-PTH2R system in
thermoregulation was also identified. TIP39 may play a role in maintaining body temper-
ature in a cold environment via descending excitatory pathways from the preoptic area.
Anatomical and functional studies also implicated the TIP39-PTH2R system in nociceptive
information processing. Finally, TIP39 induced in postpartum dams may play a role in the
release of prolactin during lactation. Potential mechanisms leading to the activation ofTIP39
neurons and how they influence the neuroendocrine system are also described.The unique
TIP39-PTH2R neuromodulator system provides the possibility for developing drugs with a
novel mechanism of action to control neuroendocrine disorders.
Keywords: neuropeptide, thermoregulation, stress response, corticotropin-releasing hormone, somatostatin,
neuroendocrine hypothalamic regulations, reproductive regulations, maternal adaptation
INTRODUCTION
The parathyroid hormone 2 receptor (PTH2R) is a member of the
family B (type II) of G-protein coupled receptors. It was discov-
ered based on its sequence similarity to other proteins belonging
to this receptor family (Usdin et al., 1995). The novel receptor was
named PTH2R because of its sequence similarity to the parathy-
roid hormone receptor and also because the human PTH2R can
be activated by parathyroid hormone (Usdin et al., 2002). In
rat, however, nanomolar concentrations of parathyroid hormone
do not cause significant activation of the PTH2R (Hoare et al.,
1999a; Figure 1). An additional difference between the parathy-
roid hormone 1 receptor (PTH1R) and the PTH2R is that the
distinct polypeptide parathyroid hormone-related peptide is a co-
ligand of the PTH1R but does not bind to the PTH2R (Hoare
et al., 1999b). A breakthrough in the field of parathyroid hormone
receptor research was the discovery of a novel peptide, tuberoin-
fundibular peptide of 39 residues (TIP39), an endogenous ligand
of the PTH2R (Usdin et al., 1999b). TIP39 was purified from
bovine hypothalamus based on its ability to elevate cAMP in a
PTH2R-expressing cell line (Usdin et al., 1999b). TIP39’s sequence
has very few amino acid residues in common with parathyroid hor-
mone and parathyroid hormone-related peptide but it does have
a similar three-dimensional structure to them (Piserchio et al.,
2000). TIP39 is a high affinity and fully potent agonist for both
the human and rodent PTH2R (Usdin et al., 1999b). Apart from
elevating cAMP (presumably via Gs proteins), TIP39 was also
shown to elevate intracellular Ca2+ levels (presumably via Gq
proteins) in some cell types (Goold et al., 2001; Della Penna et al.,
2003).
PTH2R expression is greater in the brain than in peripheral tis-
sues based on Northern blot, in situ hybridization histochemistry
and immunohistochemistry (Usdin et al., 1995, 1996, 1999a). In
the periphery, its expression pattern was also very different from
that of the PTH1R, as only a low level of expression was found
distributed in the following places: pancreatic islet somatostatin
synthesizing D cells, large vessels in bronchi, and the parenchyma
in the lung, cardiac endothelium, a small number of cells associ-
ated with the vascular pole of renal glomeruli, spermatids in the
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FIGURE 1 | Activation of rat parathyroid hormone 1 (PTH1) and PTH2
receptors. cAMP accumulation is shown in relation to increasing
concentrations of PTH, PTH-related peptide, and tuberoinfundibular peptide
of 39 residues (TIP39) in COS7 cells expressing the rat PTH1R (A) and the
rat PTH2R (B), respectively. The figure was created from data presented
previously (Hoare and Usdin, 1999; Hoare et al., 1999a; Usdin et al., 1999b).
head of the epididymis, atretic follicles of the ovary, chondrocytes
in thyroid cartilage, a small number of cells in bone, and in some
endocrine cells including thyroid parafollicular C cells, and some
gastrointestinal peptide synthesizing cells. There is relatively little
information on the effects of PTH2R signaling outside the brain
and potential functions in the periphery are not discussed in this
review.
Within the brain, the distributions of TIP39 axon terminals
and PTH2R immunoreactivity show remarkable similarities as
described below. Therefore, it was suggested that TIP39 is the
endogenous ligand of the PTH2R. Consequently, it has been pro-
posed that TIP39 and the PTH2R form a neuromodulator system
in many brain regions. This is supported by the very similar pheno-
types of mutant mice lacking either functional PTH2Rs or TIP39
or wild type (WT) animals administered a PTH2R antagonist as
discussed below.
THE DISTRIBUTION OF THE TIP39-PTH2R SYSTEM
NEURONS EXPRESSING TIP39, THE LIGAND OF THE PTH2R
TIP39-expressing cells in the adult brain are restricted to the
subparafascicular area of the thalamus and the medial paralem-
niscal nucleus of the pons as revealed by immunohistochemistry
and in situ hybridization histochemistry (Dobolyi et al., 2003b)
while the amygdala-hippocampal transitional zone also contains
some TIP39 neurons during embryonic development (Brenner
et al., 2008). The subparafascicular area TIP39 neurons were sub-
divided into the medially located group in the periventricular
gray of the thalamus (PVG) and a laterally positioned group of
the posterior intralaminar complex (PIL) of the thalamus (PIL;
Dobolyi et al., 2010; Figure 2). Recent evidence supports the idea
that the anatomical separation of these cell groups is concomi-
tant with different functions. TIP39 appears in neurons in the
PIL earlier during ontogenic development and largely disappears
from them immediately after birth (Brenner et al., 2008). In turn,
a marked induction of TIP39 in PIL cells but not in PVG cells
can be observed in postpartum dams (Cservenak et al., 2010).
Although the possibility that the PTH2R has another endoge-
nous ligand apart from TIP39 is theoretically not excluded, the
similarity in their distributions argues that TIP39 is available to
activate PTH2Rs wherever they are present in the brain. Thus,
neurons in the three sites of TIP39 expression would provide all
information necessary to act via the PTH2R in the brain. Some
evidence is available from lesion and tracer studies that TIP39
neurons in the subparafascicular area project to forebrain lim-
bic and hypothalamic regions while TIP39 neurons in the medial
paralemniscal nucleus provides TIP39 fibers to the hindbrain and
spinal cord potentially affecting auditory and nociceptive func-
tions (Dobolyi et al., 2003a; Wang et al., 2006b; Palkovits et al.,
2010).
TIP39 AND THE PTH2R IN THE PITUITARY AND MEDIAN EMINENCE
Neither TIP39 nor PTH2R mRNA or protein were found in the
pituitary (Usdin et al., 1999a; Dobolyi et al., 2002). In contrast,
PTH2R-containing fibers were abundant in the external zone
of the median eminence. PTH2R was found here in somato-
statin fibers but not in fibers containing growth hormone (GH)-,
gonadotropin-, or corticotropin-releasing hormones (CRH), or
arginine-vasopressin (AVP; Dobolyi et al., 2006a). As opposed to
the PTH2R, only a few TIP39-ir fibers were present in the median
eminence. This is in fact the most striking difference between the
otherwise very similar distributions of TIP39 axon terminals and
the PTH2R.
THE SIMILARITIES BETWEEN THE DISTRIBUTION OF THE PTH2R AND
TIP39 IN THE BRAIN
The distribution of PTH2R fibers and PTH2R-expressing cells
is generally similar in the brain and particularly so in the neu-
roendocrine hypothalamus (Wang et al., 2000; Faber et al., 2007).
However, it has to be pointed out that while the labeling pat-
tern of cell bodies provided by immunocytochemistry and in situ
hybridization histochemistry was very similar in the rat (Wang
et al., 2000), PTH2R-labeled cell bodies were mostly not visi-
ble by immunohistochemistry in the mouse, non-human primate
and human (Faber et al., 2007; Bago et al., 2009). Nevertheless,
in situ hybridization histochemistry and X-Gal histochemistry in
mice expressing beta-galactosidase driven by the promoter of the
PTH2R revealed a similar expression pattern of the PTH2R in
these species as well (Faber et al., 2007; Bago et al., 2009). The find-
ing that PTH2R-immunopositive fibers are often localized in the
vicinity of PTH2R-expressing neurons suggests that these fibers
may represent either axons or dendrites of local PTH2R-expressing
neurons. Colocalization of the PTH2R with vesicular glutamate
transporters suggests its axonal localization as described below
in Section “Development of Fear.” Interestingly, the distributions,
and even the subregional distributions of TIP39- and PTH2R-
containing axon terminals are remarkably similar (Dobolyi et al.,
2006a; Faber et al., 2007). Thus, TIP39 axon terminals and the
PTH2R are co-distributed in the very same brain structures allow-
ing the presynaptic modulation of PTH2R axon terminals. There-
fore, an axo-axonal action of TIP39 is plausible (Dobolyi et al.,
2010). However, there is no evidence available at present based on
which the dendritic localization of the PTH2R can be excluded. In
particular, electron microscopic investigation of the PTH2R has
not been reported yet.
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FIGURE 2 |TIP39 neurons in the subparafascicular area. The
subparafascicular area is a mediolaterally and to some degree rostrocaudally
elongated region. Most TIP39 cells are located in its mediorostral portion, the
periventricular gray of the thalamus (A) and in its caudolateral part, the
posterior intralaminar complex of the thalamus (B). The area where TIP39
neurons are distributed is shown in red. A few TIP39 neurons are scattered
between these two regions below the fasciculus retroflexus and above the
medial lemniscus. Additional abbreviations: ca, cerebral aqueduct; cc, corpus
callosum; CG, central gray; DG, dentate gyrus; fr, fasciculus retroflexus; H,
hippocampus; ic, internal capsule; MG, medial geniculate body; ml, medial
lemniscus; mt, mamillothalamic tract; PH, posterior hypothalamus; Pir,
piriform cortex; PVG, periventricular gray; SC, superior colliculus;SN,
substantia nigra; SNl, substantia nigra, lateral subdivision; SPFl, lateral
(parvocellular) subparafascicular nucleus; SPFm, magnocellular
subparafascicular nucleus; VB, ventrobasal thalamus. The original drawings
are modifications of panels from a rat brain atlas (Paxinos and Watson, 2007).
THE TIP39-PTH2R NEUROMODULATOR SYSTEM IN HYPOTHALAMIC
AREAS EXPRESSING NEUROENDOCRINE HORMONES
A high density of PTH2R-expressing cells and TIP39- and PTH2R-
containing fibers is present in the medial preoptic nucleus and
some surrounding parts of the medial preoptic area (Dobolyi
et al., 2006a; Faber et al., 2007). A TIP39-PTH2R neuromodula-
tor system is also abundant in the paraventricular and periven-
tricular nuclei while other parts of the anterior hypothalamic
region contain a lower density of labeling. Thus, TIP39 termi-
nals are ideally positioned to influence somatostatin and CRH
neurons. It has indeed been demonstrated that somatostatin neu-
rons express the PTH2R (Wang et al., 2000; Dobolyi et al., 2006a)
and that both TIP39- and PTH2R-containing terminals approx-
imate CRH-expressing neurons in the parvicellular subdivision
of the hypothalamic paraventricular nucleus (PVN; Bago et al.,
2009; Dimitrov and Usdin, 2010). Similarly, in the tuberal region
of the hypothalamus, the arcuate nucleus contains the highest den-
sity of PTH2R-expressing cells and TIP39- and PTH2R-containing
fibers, providing an anatomical basis for influencing GH and pro-
lactin release via GH-releasing hormone (GHRH) and dopamine
neurons in the arcuate nucleus (Table 1).
TIP39 AND THE PTH2R IN HYPOTHALAMIC, LIMBIC, AND SENSORY
BRAIN REGIONS THAT POTENTIALLY EXERT INFLUENCE ON THE
NEUROENDOCRINE SYSTEM
In the nervous system, TIP39 fibers and the PTH2R have a wide-
spread distribution pattern (Wang et al., 2000; Dobolyi et al.,
2003b; Faber et al., 2007; Bago et al., 2009). A number of brain
regions known to affect the neuroendocrine system via neuronal
projections to hypophysiotropic neurons were shown to con-
tain a high density of PTH2R-expressing cell bodies as well as
TIP39- and PTH2R-containing fibers. These brain regions include
the medial prefrontal, especially the infralimbic cortex, the lat-
eral septal nucleus, the bed nucleus of the stria terminalis, the
amygdala, especially its medial and central nuclei, some midline
and intralaminar thalamic nuclei, several hypothalamic nuclei,
the periaqueductal gray, the lateral parabrachial nuclei, the locus
coeruleus and subcoeruleus areas, and the nucleus of the solitary
tract. Within the hypothalamus, the following nuclei contained
a high level of TIP39 and PTH2R apart from the above men-
tioned neuroendocrine regions: the MnPO, the vascular organ
of the lamina terminalis, the dorsomedial and perifornical hypo-
thalamic nuclei, and some parts of the lateral hypothalamic area
including the so-called far-lateral hypothalamus immediately next
to the internal capsule, the medial subdivision of the supramamil-
lary nucleus, the ventral, and dorsal premamillary nuclei, and the
posterior hypothalamic nucleus, (Wang et al., 2000; Dobolyi et al.,
2003b; Faber et al., 2007; Bago et al., 2009). In contrast, TIP39 and
the PTH2R are scarce in a number of hypothalamic nuclei includ-
ing the lateral preoptic area, the supraoptic, suprachiasmatic, and
lateroanterior hypothalamic nuclei, the medial magnocellular part
of the paraventricular nucleus, the ventromedial nucleus, and the
medial and lateral nuclei of the mamillary body (Table 1).
TIP39 AND THE PTH2R IN REGIONS OF THE NERVOUS SYSTEM NOT
INVOLVED IN NEUROENDOCRINE REGULATIONS
Elements of the TIP39-PTH2R neuromodulator system are also
expressed in some brain regions that are not known to be directly
or indirectly involved in neuroendocrine regulation. Thus, TIP39
as well as PTH2R fibers were abundant in the fundus striati, the
medial geniculate body, tegmental areas of the midbrain and pons,
the deep layers of the superior colliculus, the external cortex of the
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Table 1 |The distribution ofTIP39 axon terminals and the PTH2R in the nervous system.
Areas containing a high density ofTIP39 fibers and PTH2R
Neuroendocrine hypothalamic areas Medial preoptic area, paraventricular nucleus, periventricular nucleus, arcuate nucleus
Brain regions that potentially exert influence on the
neuroendocrine system
Infralimbic cortex, lateral septal nucleus, the bed nucleus of the stria terminalis, medial and
central amygdaloid nuclei, the vascular organ of the lamina terminalis, dorsomedial and
perifornical hypothalamic nuclei, far-lateral and posterior hypothalamic areas, the medial
subdivision of the supramamillary nucleus, premamillary nuclei, paraventricular, reuniens,
posterior intralaminar, and subparafascicular thalamic nuclei, periaqueductal gray, lateral
parabrachial nuclei, the locus coeruleus and subcoeruleus areas, and the nucleus of the solitary
tract
Regions of the nervous system not directly involved in
neuroendocrine regulations
Fundus striati, the medial subdivision of the medial geniculate body, tegmental areas of the
midbrain and pons, deep layers of the superior colliculus, the external cortex of the inferior
colliculus, the periolivary area, the nucleus of the trapezoid body, the superficial layers of the
dorsal horn, the lateral cervical nucleus of the spinal cord, and some primary sensory neurons
inferior colliculus, the periolivary area, the nucleus of the trape-
zoid body, the superficial layers of the dorsal horn and the lateral
cervical nucleus of the spinal cord, and some cells in the dorsal root
ganglia (Wang et al., 2000; Dobolyi et al., 2003b; Faber et al., 2007;
Bago et al., 2009; Matsumoto et al., 2010). Several of these brain
regions may participate in sensory, especially auditory information
processing, which could represent non-neuroendocrine-related
functions of the TIP39-PTH2R neuromodulator system. How-
ever, a potential role of TIP39 in the auditory stress pathway will
be discussed later.
NEUROENDOCRINE FUNCTIONS THAT MAY INVOLVE THE
TIP39-PTH2R SYSTEM
Based on the distribution of the TIP39-PTH2R system in the brain,
its involvement in endocrine, limbic, nociceptive, and auditory
functions have been hypothesized (Dobolyi et al., 2003a). These
functions can of course be interrelated with each other. Initial
studies in which PTH2Rs were activated with exogenous TIP39 as
well as in vitro approaches provided some insights into the possible
functions of the TIP39-PTH2R system. More recently, a selective
and potent peptide antagonist of the PTH2R (Kuo and Usdin,
2007) and transgenic mice lacking functional TIP39 and PTH2R
genes were developed (Fegley et al., 2008), which accelerated func-
tional studies. It has indeed been established that the peptide
neuromodulator system is involved in a variety of neuroendocrine
functions including the stress response, thermoregulation, and
prolactin release. Some evidence is also available for a role of the
TIP39-PTH2R system in the regulation of AVP and GH release.
STRESS RESPONSE
The stress response is a complex reaction of the organism to stimuli
that threaten homeostasis. The stress response includes an altered
psychological state called anxiety and physiological effects that
include catecholamine and glucocorticoid release as final com-
mon pathways (Kvetnansky et al., 2009). The anxiety level and
the hormone secretions interact to provide the organisms stress
response.
The regulation of CRH function
The first functional evidence that the PTH2R might be involved
in the regulation of CRH release came from an in vitro study.
TIP39 increased CRH secretion from medial basal hypothalamic
explants (Ward et al., 2001). In addition, intracerebroventricular
injection of TIP39 dose-dependently increased the plasma adreno-
corticotropin (ACTH) level at 10 min after injection in rat (Ward
et al., 2001). In another study, local injection of TIP39 above the
paraventricular hypothalamic nucleus (PVN) in mice also ele-
vated plasma corticosterone levels in addition to increasing the
number of pCREB-containing activated cells in and around the
PVN (Dimitrov and Usdin, 2010). Most importantly, these effects
of local TIP39 were not present in PTH2R knockout (KO) ani-
mals (Dimitrov and Usdin, 2010) excluding non-specific actions
of TIP39 injection. These results suggest that the TIP39-PTH2R
system is positioned and available to potentially modulate acti-
vation of the hypothalamus-pituitary-adrenal (HPA) axis. In fact,
the activation of TIP39 neurons has been reported in some stress
situations as described below in Section “The Activation of TIP39
Neurons.” Furthermore, the daily peak of the basal plasma cor-
ticosterone level was reduced in TIP39 KO mice suggesting that
endogenous TIP39 plays a role in the circadian regulation of cor-
ticosterone levels (Dimitrov and Usdin, 2010). These findings are
consistent with a high density of TIP39 fibers, PTH2R-expressing
cells, and PTH2R-containing fiber terminals in the parvicellular
subdivisions of the PVN (Faber et al., 2007). In fact, close appo-
sition between CRH neurons and PTH2R-containing fibers has
been demonstrated in mice (Dimitrov and Usdin, 2010) as well as
in human (Bago et al., 2009).
The regulation of noradrenergic function
The involvement of the PTH2R in the regulation of the cat-
echolamine systems is less well established even though TIP39
fibers are abundant in the locus coeruleus and subcoeruleus areas
(Dobolyi et al., 2003b) where rostrally projecting noradrenergic
neurons reside. Recent evidence brings up the possibility that
TIP39 may interact with some noradrenergic pathways. TIP39 KO
mice and WT mice injected with a PTH2R antagonist demon-
strated selective impairment of memory performance during
novelty-induced arousal (Coutellier et al., 2011a). Noradrenergic
signaling has a biphasic, inverted U shaped, effect on cognitive
functions (Arnsten, 2009). The impaired performance of mice
without TIP39/PTH2R signaling was restored by propranolol, an
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antagonist of beta adrenoceptors, suggesting that PTH2R signal-
ing influences the effect of novelty stress via an interaction with
noradrenergic mechanisms (Coutellier et al., 2011a).
Stress-induced analgesia
In an experiment addressing the role of PTH2R signaling in stress-
induced analgesia (SIA), hotplate tests were performed before and
after an inescapable foot shock, used as the stressful stimulus
(Dimitrov et al., 2010). As discussed in a later section, TIP39 KO
and PTH2R KO mice as well as WT mice injected with a PTH2R
antagonist had somewhat elevated pre-shock response latencies in
the hotplate test. Following the foot shock, the response latencies
increased in the WT mice as expected based on the phenomenon
of SIA. Unexpectedly, a larger and dramatic increase was found
in the response latency in mice without PTH2R signaling (Dim-
itrov et al., 2010). These findings suggest that signaling through
the TIP39-PTH2R system may normally limit SIA.
Stress-induced analgesia induced by high intensity stressful
stimuli, including inescapable foot shock, has been shown to have
a predominant non-opioid component (Lewis et al., 1980; Terman
et al., 1984). Indeed the opioid antagonist naloxone did not, but the
CB1 cannabinoid receptor antagonist rimonabant did, decrease
the SIA in WT mice (Dimitrov et al., 2010). The inhibitory effect
of rimonabant on the SIA was much greater in the KO mice sug-
gesting that the KO mice have greater endocannabinoid release or
sensitivity and that endogenous TIP39, via the PTH2R, may neg-
atively modulate release or an effect of endogenous cannabinoids
during SIA.
RELEASE OF ARGININE-VASOPRESSIN
The role of the PTH2R on the release of AVP was investigated
by intracerebroventricular injection of TIP39 in rats (Sugimura
et al., 2003). Reduced AVP levels were found in plasma 5 min fol-
lowing TIP39 administration. TIP39 also suppressed the plasma
AVP increase following dehydration by water deprivation for 48h,
hyperosmolality following i.p. injection of hypertonic saline, and
hypovolemia following i.p. injection of polyethylene glycol. These
inhibitory effects cannot be attributed to a decrease in the level
of osmotic or hypovolemic stimulation because plasma Na+ and
plasma total protein were not affected by the injection of TIP39
(Sugimura et al., 2003). The effect of TIP39 was also not a conse-
quence of a change in blood pressure because injection of TIP39
produced a fall in mean arterial blood pressure,which would rather
stimulate AVP secretion. In turn, the opioid receptor antagonist
naloxone significantly reversed the inhibitory effect of TIP39 on
dehydration-induced AVP release while it had no significant effect
on the plasma AVP level when injected alone (Sugimura et al.,
2003). These results suggest that TIP39 inhibits AVP release by
central action – possibly via an opioid system but without hemo-
dynamic or osmotic influence. The effect was rapid and did not last
long suggesting that TIP39 may play a role in the dynamic regula-
tion of AVP release. TIP39 and PTH2R are scarce in the supraoptic
nucleus and the part of the PVN where magnocellular AVP neu-
rons are located. Thus, TIP39 may exert its AVP release-inhibitory
effect by acting through other hypothalamic nuclei. The hypothal-
amic arcuate nucleus is a candidate as it contains a high density of
TIP39 and PTH2R immunoreactivity (Faber et al., 2007) as well as
many opioid neurons, which are involved in the regulation of AVP
release (Haaf et al., 1987; Heijning et al., 1991). Indirect action of
TIP39 via hypothalamic angiotensin and atrial natriuretic peptide
neurons affecting AVP release (Antunes-Rodrigues et al., 2004) is
also conceivable.
GROWTH HORMONE SECRETION
In a preliminary experiment, TIP39 injection into the lateral
ventricle of male rats blocked the appearance of GH almost
completely in plasma for the next 3 h (Usdin et al., 2003). This
finding is consistent with anatomical data showing a high den-
sity of TIP39-containing fibers around somatostatin neurons in
the periventricular hypothalamic nucleus. Somatostatin neurons
in this area project to the median eminence and inhibit the
release of GH (Luque et al., 2008). PTH2R expression was demon-
strated on many of these somatostatin neurons in the rat (Usdin
et al., 1999b) as well as in human (Bago et al., 2009) provid-
ing the anatomical basis for TIP39 stimulating the release of
somatostatin, which in turn inhibits GH secretion (Luque et al.,
2008).
PHYSIOLOGICAL ACTIONS OF TIP39 NOT DIRECTLY RELATED
TO ITS NEUROENDOCRINE EFFECTS
EFFECTS ON THE ANXIETY LEVEL
The anxiety levels of animals may also be affected by the TIP39-
PTH2R system. In the elevated plus maze, a test of anxiety, intrac-
erebroventricular injections of TIP39 in rats resulted in increased
open arm entries and duration as compared to controls (animals
receiving the inactive TIP (7–39) or saline) while no differences
were observed between groups in the number of closed arm entries
or total arm entries, suggesting an anxiolytic-like effect of TIP39
(LaBuda et al., 2004). The TIP39-PTH2R system in the infral-
imbic cortex, lateral hypothalamus, preoptic area, lateral septum,
and the paraventricular thalamic nucleus could be involved in this
action because TIP39 administration induced Fos activation in
these brain regions (LaBuda et al., 2004). In the forced-swim test,
a similar TIP39 administration reduced the duration of immobil-
ity, and increased the amount of climbing behavior (LaBuda et al.,
2004) suggesting an anti-depressant-like action of TIP39. The phe-
notype of TIP39 KO mice is also consistent with an anxiolytic role
of endogenous TIP39. TIP39 KO mice demonstrated increased
anxiety in the shock-probe defensive burying test as compared to
WT controls. In “standard/low stress” testing conditions, TIP39
KO mice did not differ from WT controls in the arm entries in the
elevated plus maze or in the dark-light emergence test of spon-
taneous anxiety-like behaviors (Fegley et al., 2008). However, an
increase in anxiety-like behavior became apparent in TIP39 KO
mice that were tested in the elevated plus maze under conditions
of mildly increased stress evoked by either brief prior restraint
or bright illumination. These results are consistent with a role
of endogenous TIP39 in limiting the consequences of stressful
perturbations. Furthermore, mice lacking TIP39 or the PTH2R
demonstrated increased anxiety- and depression-like behaviors
16–17 days but not 7–9 days after a foot shock in elevated-zero
maze, open field, light-dark box and forced-swim tests (Coutellier
and Usdin, 2011).
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DEVELOPMENT OF FEAR
Closely related to anxiety, fear has also been investigated in relation
with the TIP39-PTH2R system using Pavlovian fear condition-
ing (Fegley et al., 2008). TIP39 KO mice showed more freezing
than WT controls after only one tone-shock pairing during con-
ditioning and, subsequently, more freezing during both tone- and
context-recall tests (Fegley et al., 2008). However, based on a
similar rate of decline in freezing responses to repeated tone pre-
sentation and a similar level of freezing during subsequent tone
presentation, there did not appear to be an effect of TIP39 deletion
on fear extinction learning or extinction recall, respectively (Feg-
ley et al., 2008). Furthermore, foot shock conditioned fear recall
was enhanced 14 days but not 6 days after the aversive stimulus in
both TIP39 KO and PTH2R KO mice as compared to WT controls
(Coutellier and Usdin, 2011). These results suggest that normal
TIP39 signaling lessens the long-term consequences of a trau-
matic event while the absence of signaling via the PTH2R delays
recovery. Since the amygdala is known to be involved in the fear
response (LeDoux, 2003), the abundant TIP39-PTH2R system in
the amygdala, especially in its central and medial nuclei (Faber
et al., 2007), might be involved in these effects.
THERMOREGULATION
Body temperature regulation is a fundamental homeostatic func-
tion that in homeothermic animals. Thermal information on envi-
ronmental temperature sensed by skin thermoreceptors ascends
to the MnPO in the hypothalamic preoptic area. GABAergic
inhibitory neurons in the MnPO integrate this input with local
thermal influences and project to the dorsomedial hypothala-
mic nucleus and the rostral medullary raphe region to restore
homeostasis (Nakamura, 2011). Injection of TIP39 into the lat-
eral ventricle increased the core temperature of WT mice while
TIP39 injection had no effect in PTH2R KO mice, excluding the
possibility of non-specific inflammatory actions (Dimitrov et al.,
2011). Furthermore, PTH2R KO mice had impaired heat pro-
duction upon cold exposure, but no change in basal temperature
and no impairment in response to a hot environment suggesting
that the TIP39-PTH2R system plays a specific role in tempera-
ture conservation in a cold environment (Dimitrov et al., 2011).
Since temperature sensation was normal in PTH2R KO mice, the
PTH2R may play a role in the heat production signal or heat
production ability. Both seem to be the case because acute intrac-
erebral PTH2R antagonist administration also impaired the heat
production response to a cold environment, though to a smaller
extent. In addition, the weight of brown adipose tissue (BAT), and
its capacity to increase body temperature were reduced. PTH2Rs
in the MnPO seem to be involved in the thermoregulatory action
of TIP39 because TIP39 injected locally into the MnPO produced
a larger body temperature increase (2˚C) for longer periods of
time than injection of the same amount of TIP39 into the lateral
ventricle. Furthermore, local injection of TIP39 into the dorsome-
dial hypothalamic nucleus had no effect on the body temperature.
The MnPO as a site of action is consistent with its high density of
TIP39 terminals and PTH2R immunoreactivity (Faber et al., 2007;
Dimitrov et al., 2011) as well as with the known role of MnPO neu-
rons in the control body temperature (Baffi and Palkovits, 2000;
Bratincsak and Palkovits, 2004) via descending systems regulating
BAT thermogenesis and cutaneous vascular tone (Morrison and
Nakamura, 2011). The action of TIP39 on the HPA axis and in
central thermoregulation allows associations with fever. Although
no data are available in this regard, this potential role of the
TIP39-PTH2R system will be an interesting line of research in
the future.
NOCICEPTIVE FUNCTIONS
The TIP39-PTH2R system may play a role at several levels of noci-
ceptive processing. Its role in nociceptive sensation and spinal
cord processing has been revealed by intrathecal administration
of TIP39 and antagonizing its actions with the injection of an
anti-TIP39 antibody (Dobolyi et al., 2002). Intrathecal injection
of TIP39 stimulated a dose-dependent nocifensive response, cau-
dally directed scratching, biting, and licking and decreased the
tail-flick and paw-pressure withdrawal latencies. Intrathecal injec-
tion of the TIP39 antibody increased the response latency in the
thermal tail-flick assay and in the paw-pressure test, correspond-
ing to decreased sensitivity (Dobolyi et al., 2002). These actions
are likely related to the facilitation of nociceptive transmission
from the DRG to neurons in the spinal cord dorsal horn as intense
PTH2R immunoreactivity is present in superficial layers of the
spinal cord dorsal horn where most nociceptive afferents terminate
(Wang et al., 2000).
The TIP39-PTH2R system may also be involved in the
supraspinal regulation of pain processing. Intracerebroventric-
ular injection of TIP39 reduced the latencies in tail-flick and
hotplate tests while injection of a PTH2R antagonist had the
opposite, anti-nociceptive effect in these tests as well as in
the formalin test (Dimitrov et al., 2010). Furthermore, TIP39
and PTH2R KO mice also demonstrated reduced nociceptive
responses in these tests, arguing for a pro-nociceptive function
of endogenous TIP39 via the PTH2R (Dimitrov et al., 2010).
These findings are consistent with the distribution of TIP39
and the PTH2R in a variety of brain regions known to be
involved in the processing of nociceptive information, includ-
ing the nucleus of the solitary tract, the parabrachial nuclei,
the periventricular gray, the midline thalamic nuclei, the PVN,
and the insular and infralimbic cortices. These areas are thought
to be components of autonomic-limbic pain-related pathways
including the ascending reticular activating system (Benarroch,
2006).
REGULATION OF POSTPARTUM EVENTS IN MOTHERS
TIP39 expression is decreased in neurons in both the subparafasci-
cular area and the MPL during the period of pubertal development
in rat (Dobolyi et al., 2006b). Since the level of the PTH2R did not
decrease, it was hypothesized that TIP39 is induced under some
circumstances to act on the already available PTH2Rs. Indeed, a
dramatic increase in the TIP39 mRNA levels was demonstrated
in the postpartum period using real-time PCR. Upon removal
of the pups, the level of TIP39 mRNA decreased to its basal
level. In situ hybridization histochemistry confirmed the induc-
tion of TIP39 and revealed that within the subparafascicular area,
TIP39 neurons in the PIL but not in the PVG demonstrated an
increase in TIP39 expression (Cservenak et al., 2010). The ele-
vated mRNA of TIP39 in the PIL and MPL is translated into
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increased peptide levels, as demonstrated by immunohistochem-
istry (Varga et al., 2008; Cservenak et al., 2010). The functional
significance of the elevated TIP39 was tested on the release of pro-
lactin because pathway transections revealed projection of TIP39
neurons in the PIL toward tyrosine hydroxylase-containing neu-
rons in the mediobasal hypothalamic regions known to regulate
prolactin secretion. Retrograde labeling in nulliparous female rats
also demonstrated a projection of subparafascicular TIP39 neu-
rons to the arcuate nucleus (Szabo et al., 2010). In rodents, removal
of the pups from the dams for 4h results in a decrease in prolactin
level, which is in turn dramatically increased upon the return
of the litter and the immediate onset of nursing. Injection of a
PTH2R antagonist into the lateral ventricle 5 min before uniting
the mothers with pups potently and dose-dependently inhibited
suckling induced prolactin release in the rat (Cservenak et al.,
2010). The physiological significance of this is supported by the
observation that in a similar pup removal/return paradigm the
weight increase (a measure of milk consumed) of pups suckling
PTH2R KO mice was reduced 30 min after the onset of nursing
as compared to pups suckling WT mice (Coutellier et al., 2011b).
Also consistent with less effective suckling by PTH2R KO dams,
pups reared by PTH2R KO mice had a lower body weight at
the time of weaning than pups reared by WT mice (Coutellier
et al., 2011b). To eliminate the effect of the genotype of the pups
from the analysis, WT females were mated with PTH2R KO males
while PTH2R KO females were mated with WT males so that all
pups were heterozygous in these experiments (Coutellier et al.,
2011b).
Additional influences of subparafascicular TIP39 neurons on
reproductive neuroendocrine function cannot be excluded. TIP39
fibers and PTH2Rs are ideally positioned to affect gonadotropin-
releasing hormone (GnRH) neurons, whose activity is suppressed
during lactation. In addition, the TIP39-PTH2R neuromodulator
system might also play a role in conveying the effect of suckling
on other systems adapted in the postpartum period. PTH2Rs in
the preoptic area, the lateral septum, and the periaqueductal gray
could be involved in the control of maternal behaviors (Dobolyi,
2011). Emotional changes that take place in the postpartum period
could also be affected by TIP39 based on the localization of
the TIP39-PTH2R system in the infralimbic cortex, the medial,
and central amygdaloid nuclei, the amygdalo-hippocampal tran-
sitional zone, the premamillary nuclei, the ventral subiculum, and
the periaqueductal gray, which are parts of the circuitry of repro-
ductive and emotional regulation (Lonstein and Stern, 1997; Lin
et al., 1998; Li et al., 1999; Simerly, 2002; Numan and Insel, 2003;
Hasen and Gammie, 2005).
POSSIBLE MODELS FOR ACTIONS VIA THE TIP39-PTH2R
SYSTEM
THE ACTIVATION OF TIP39 NEURONS
There is limited information available showing that TIP39 neu-
rons are activated in stress situations. At present, only the effects
of an h-long high intensity noise stress have been reported. Medial
paralemniscal and posterior intralaminar TIP39 neurons demon-
strate Fos induction together with CRH neurons in response to
noise stress, suggesting that TIP39 neurons could be involved in
the transmission of acoustic stress derived information to CRH
neurons in the PVN (Palkovits et al., 2009). In agreement with
these findings, medial paralemniscal and possibly also posterior
intralaminar TIP39 neurons have afferent neuronal connections
with the primary auditory cortex and the external cortex of the
inferior colliculus (Varga et al., 2008) providing the anatomical
basis for an auditory influence on the CRH neurons in the PVN.
Cold exposure but not warm ambient temperature induced c-
fos in some PVG neurons (Kiyohara et al., 1995; Miyata et al.,
1995; Baffi and Palkovits, 2000; Bratincsak and Palkovits, 2004)
providing the possibility that TIP39 neurons in this region could
be activated by cold exposure leading to both stress responses
and temperature regulation. It has also been reported that the c-
fos expression in the PVG significantly outlasts the cold exposure
(Miyata et al., 1995), suggesting that it may have a role in the main-
tenance of homeostasis during adaptation to cold stress (Baffi and
Palkovits, 2000).
The PVG is a site of stimulation-induced analgesia (Rhodes and
Liebeskind, 1978; Peschanski and Mantyh, 1983). Potent analge-
sia is obtained in rats following electrical stimulation in the gray
matter surrounding the caudal portion of the third ventricle and
the midline area of the caudal thalamus that is comparable to that
produced by stimulation of the caudal periaqueductal gray. Anal-
gesia outlasts the period of brain stimulation, and is not due to a
generalized motor debilitation of the animal (Rhodes and Liebe-
skind, 1978). In addition, some neurons in the area are activated
by noxious stimuli (Dong et al., 1978; Sugiyama et al., 1992) pro-
viding the possibility that TIP39 neurons in this region could be
activated by noxious stimuli leading to both stress and nociceptive
responses.
The TIP39-PTH2R neuromodulator system is present in sev-
eral brain areas that are activated in males following mating
(Sachs and Meisel, 1988; Coolen et al., 1997; Veening and Coolen,
1998) including the PIL, the medial preoptic nucleus, the pos-
teromedial part of the medial subdivision of the bed nucleus
of the stria terminalis, and the posterodorsal subdivision of the
medial amygdaloid nuclei. In addition, the PIL, which contains
TIP39 neurons, has also been implicated in sexual functions
via the facilitation of copulatory behavior by current injec-
tion into the area (Shimura and Shimokochi, 1991), by the
decreased sexual behavior following lesion in the area (Maillard
and Edwards, 1991), and by the demonstration of the activa-
tion of neurons in the area following sexual behavior using the
Fos technique in rats (Coolen et al., 1997) and imaging tech-
niques in human (Holstege et al., 2003). Indeed, TIP39 neurons
in the PIL have been shown to exhibit Fos expression follow-
ing ejaculation (Wang et al., 2006a). This suggests that these
TIP39 neurons are part of the afferent circuits that process
genital-somatosensory information related to ejaculation con-
tributing to mating and mating-induced changes in reproductive
behaviors.
Another reproductive influence reaching TIP39 neurons in the
PIL was reported in mother rats. Dams deprived of their pups
for a day demonstrated c-fos expression in the PIL but not in the
PVG in response to reunion with their litter (Cservenak et al.,
2010). Almost all TIP39 neurons in the PIL were involved in this
response. Since the pups start to suckle very soon after they are
returned to their mothers, it was hypothesized that suckling results
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in the activation of TIP39 neurons in the PIL (Cservenak et al.,
2010).
THE POTENTIAL MECHANISMS OF ACTION OF TIP39
There are no indications at present that TIP39 would have any
action apart from activating the PTH2R. The PTH2R elevates
cAMP and in some cells also increases Ca2+ levels (Goold et al.,
2001; Della Penna et al., 2003) suggesting an excitatory influence
of TIP39 on the target cells. In some cases, the PTH2R may be
located in cell bodies and dendrites, there is evidence for this
for the somatostatin neurons in the rat periventricular nucleus.
Most typically, the PTH2R may be located in axon terminals.
Apart from the somatostatin terminals in the median eminence
(Dobolyi et al., 2006a), a presynaptic location of the PTH2R at
excitatory synapses has been demonstrated in several hypothala-
mic areas (Figure 3). In the PVN, vesicular glutamate transporter
2 (VGluT2)-containing terminals closely apposed to CRH neu-
rons were shown to also contain the PTH2R (Dimitrov and Usdin,
2010). In addition, the close apposition by TIP39-containing ter-
minals suggested that TIP39 from the subparafascicular area might
also contribute to the activation of CRH neurons by increasing the
efficacy of the excitatory input to the CRH neurons (Dimitrov and
FIGURE 3 | Colocalization of PTH2R fibers and VGluT2 punctae in the
anterior hypothalamus as detected by immunohistochemistry. (A) a
low magnification image of PTH2R (green) and VGluT2 (red) expression in
the region of the medial preoptic area. (B) a high magnification image of
PTH2R/VGluT2 colocalization, where some of the colocalized points are
indicated with arrowheads. Abbreviations: 3V, third ventricle; ac, anterior
commissural; AHA, anterior hypothalamic area; MPO, medial preoptic
nucleus of the hypothalamus. Scale bars=200 µm for A and 10 µm for B.
FIGURE 4 | Colocalization of VGluT2 mRNA and PTH2R mRNA in the
anterior hypothalamus as detected by fluorescent in situ
hybridization. (A) VGluT2 mRNA (red puncta) over cell nuclei (blue, DAPI).
(B) PTH2R mRNA (green puncta) over cell nuclei (blue, DAPI). (C) a merged
image, where the arrows point to cells expressing both PTH2R/VGluT2
mRNAs and the arrowhead points to a neuron with only VGluT2 signal.
Scale bar=10 µm.
Usdin, 2010). In a similar fashion, median preoptic neurons pro-
jecting to the dorsomedial hypothalamic nucleus for the potential
transfer of thermoregulatory information were also suggested to
be modulated by TIP39 via presynaptic excitation of their afferents
(Dimitrov et al., 2011). Expression of the PTH2R by glutamater-
gic neurons in several brain regions is supported by data from
in situ hybridization histochemistry (Figure 4). In other cases,
the effect of TIP39 on inhibitory neurons has also been postu-
lated based on functional data (Sugimura et al., 2003; Cservenak
et al., 2010). Thus, the inhibition of AVP neurons and dopamin-
ergic neurons is expected from the actions of TIP39 on the serum
levels of AVP and prolactin, respectively. This inhibition could
be carried out via potentiation of excitatory inputs to inhibitory
interneurons acting on the AVP and dopaminergic neurons,
respectively.
FIGURE 5 | Potential mechanisms of actions ofTIP39 via the PTH2R.
TIP39 neurons in the PVG receive information on threats to homeostasis
while those in the PIL receive various inputs related to reproduction. Axon
terminals arising from these TIP39 neurons may facilitate excitatory
synapses by presynaptic actions. A well-documented example is the action
of TIP39 on glutamatergic synapses terminating on CRH neurons in the
PVN. Another possible route to influence hypothalamic hormone release is
via terminals of hypophysiotropic neurons in the median eminence (ME) as
has been suggested for somatostatin. Neurons that express PTH2Rs in
their cell bodies may be directly affected by TIP39. Some actions of TIP39
including those on prolactin and AVP release, seem to be mediated by
inhibitory neurons. TIP39 terminals might innervate cell bodies of
GABAergic cells or alternatively, presynaptic terminals leading to the
activation of inhibitory neurons (not shown). Additional abbreviations:
ACTH, adrenocorticotropin; Arc, arcuate nucleus; DA, dopamine; GH,
growth hormone; Glu, glutamate; Pe, periventricular hypothalamic nucleus;
PRL, prolactin; SOM, somatostatin.
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CONCLUSION
The TIP39-PTH2R neuromodulator system may play an impor-
tant role in the regulation of several different aspects of neuroen-
docrine functions. TIP39 neurons in the PVG may be stimulated by
stress inputs compromising the homeostasis of the animal while
TIP39 neurons in the PIL may be stimulated by various repro-
ductive events (Figure 5). Additional, as yet unexplored inputs
to the TIP39 neurons are also plausible. These TIP39 neurons in
the posterior thalamus relay their input toward neurons located in
neuroendocrine and limbic brain areas to exert direct and indirect
effects on neuroendocrine systems. So far, substantial evidence is
available for the involvement of the TIP39-PTH2R system in the
regulation of corticosterone, AVP, and prolactin. These actions of
TIP39 suggest that the PTH2R may be a future target to develop
drugs for the treatment of some neuroendocrine abnormalities
and disorders.
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